Stock Price Quote

SUVEN LIFE SCIENCES LTD.

NSE : SUVENBSE : 530239ISIN CODE : INE495B01038Industry : Pharmaceuticals & DrugsHouse : Private
BSE44.202.1 (+4.99 %)
PREV CLOSE ( ) 42.10
OPEN PRICE ( ) 43.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 291497
TODAY'S LOW / HIGH ( )42.25 44.20
52 WK LOW / HIGH ( )20.3 334.9
NSE44.252.1 (+4.98 %)
PREV CLOSE( ) 42.15
OPEN PRICE ( ) 43.25
BID PRICE (QTY) 44.25 (63249)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1946879
TODAY'S LOW / HIGH( ) 40.60 44.25
52 WK LOW / HIGH ( )15.2 334.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 09-03 1989
Management Info
Venkateswarlu Jasti - Chairman - Managing Director
Registered Office

Address 8-2-334, S D E Serene Chambers,6th Floor, Road No 5, Avenue 7,Banjara Hills,
Hyderabad,
Telangana-500034

Phone +91-40- 23541142 23543311 32921695 32921696

Email info@suven.com

Website www.suven.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

10Jan Appointment of Company Secretary and
Changes in KMPs of Suven Group companies and Change in Directorship of SLSL
20Dec Suven Life Sciences receives EIR from
Suven Life Sciences has undergone USFDA renewal inspection at their faci..
19Dec Announcement under Regulation 30 (LOD
Suven receives EIR from US FDA for its Pashamylaram facility
03Dec Clarification
With reference to Movement in Volume, Suven Life Sciences Ltd has submit..
02Dec Announcement under Regulation 30 (LOD
Suven Life Sciences announces Top-Line Results of SUVN-502 (Masupirdine)..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit-45.021500.63
Gross Profit -44.6 2218.63
Operating Profit -35.072477.67
Net Sales 27.736635.04

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  2865.70 (2.94%)
M.Cap ( in Cr)7164.25
Solara Active Pharma (BSE)
peergroup  618.50 (9.05%)
M.Cap ( in Cr)1611.52
Alkem Laboratories (BSE)
peergroup  2649.40 (1.26%)
M.Cap ( in Cr)31677.55
Torrent Pharma (BSE)
peergroup  2112.30 (1.50%)
M.Cap ( in Cr)35741.96
Aarti Drugs (BSE)
peergroup  652.95 (4.46%)
M.Cap ( in Cr)1521.37

Shareholding Pattern

PROMOTERS 60%
NON-INSTITUTION 31.98%
MUTUAL FUNDS/UTI 2.06%
FI/BANKS/INSURANCE 0.13%
GOVERNMENT 0%
FII 0%

About Suven Life Sciences Ltd.

Suven Life Sciences Ltd. was incorporated in the year 1989. Its today's share price is 44.2. Its current market capitalisation stands at Rs 562.59 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6635.04 Cr and Total Income of Rs.6877.34 Cr. The company's management includes Sudha Rani Jasti, JAS Padmaja, Santanu Mukherjee, M Gopalakrishna, Seyed E Hasnain, M R Naidu, Venkateswarlu Jasti.

It is listed on the BSE with a BSE Code of 530239 , NSE with an NSE Symbol of SUVEN and ISIN of INE495B01038. It's Registered office is at 8-2-334, S D E Serene Chambers,6th Floor, Road No 5, Avenue 7,Banjara HillsHyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are Karvy & Co, Tukaram & Co, Tukaram & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X